Could Proteomic Research Deliver the Next Generation of Treatments for Pneumococcal Meningitis?
Streptococcus pneumoniae is the most common bacterial cause of community-acquired meningitis worldwide. Despite optimal antibiotic therapy and supportive care, the mortality of this condition remains very high at 20–30% in the developed world and over 60% in under-resourced hospitals. In developed c...
Main Authors: | U. R. Goonetilleke, S. A. Ward, S. B. Gordon |
---|---|
Format: | Article |
Sprog: | English |
Udgivet: |
Wiley
2009-01-01
|
Serier: | Interdisciplinary Perspectives on Infectious Diseases |
Online adgang: | http://dx.doi.org/10.1155/2009/214216 |
Lignende værker
-
Death Is Associated with Complement C3 Depletion in Cerebrospinal Fluid of Patients with Pneumococcal Meningitis
af: U. R. Goonetilleke, et al.
Udgivet: (2012-05-01) -
Corticosteroids in Pneumococcal Meningitis
af: J Gordon Millichap
Udgivet: (1991-12-01) -
Quantitative Proteomics of Cerebrospinal Fluid in Paediatric Pneumococcal Meningitis
af: Guadalupe Gómez-Baena, et al.
Udgivet: (2017-08-01) -
Pneumococcal Meningitis
af: Kelly Di Dier, et al.
Udgivet: (2022-12-01) -
Advances in the pathogenesis and treatment of pneumococcal meningitis
af: Yiyun Xu, et al.
Udgivet: (2024-12-01)